Literature DB >> 8784797

Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis.

R Penagini1, M N Schoeman, J Dent, M D Tippett, R H Holloway.   

Abstract

Information on the mechanism of gastro-oesophageal reflux in patients with reflux disease is limited largely to studies in resting recumbent subjects. Evidence exists that both posture and physical activity may influence reflux. The aim of this study was to investigate reflux mechanisms in ambulant patients with reflux oesophagitis. Concurrent ambulatory oesophageal manometry and pH monitoring were performed in 11 ambulant patients with erosive oesophagitis. Lower oesophageal sphincter (LOS) pressure was monitored with a perfused sleeve sensor. Recordings were made for 90 min before and 180 min after a meal. At set times patients sat in a chair or walked. LOS pressure was < or = 2 mmHg at the time of reflux for 98% of reflux episodes. Transient LOS relaxation was the most common pattern overall and the predominant pattern in seven patients, whilst persistently absent basal LOS pressure was the most common pattern in four patients. The pattern of LOS pressure was not altered by the presence of hiatus hernia or by walking. Straining occurred at the onset of 31% of acid reflux episodes but often followed the development of an oesophageal common cavity. The occurrence of straining was not influenced by walking. In ambulant patients with reflux oesophagitis: (1) LOS pressure is almost always absent at the time of reflux, usually because of transient LOS relaxation, (2) persistently absent basal LOS pressure is an important mechanism of reflux in a few patients, (3) straining may help to induce acid reflux in a variable proportion of occasions and may in some instances be a response to gas reflux, and (4) walking does not influence the occurrence of reflux or its mechanisms.

Entities:  

Mesh:

Year:  1996        PMID: 8784797     DOI: 10.1111/j.1365-2982.1996.tb00253.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  28 in total

1.  Anti-relaxation therapy in GORD.

Authors:  J Tack; D Sifrim
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  Effect of phasic contractions and tone of the proximal stomach on triggering of transient lower esophageal sphincter relaxation.

Authors:  M Allocca; R Penagini
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

3.  Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism.

Authors:  J C Fang; I Sarosiek; Y Yamamoto; J Liu; R K Mittal
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Acid infusion into the esophagus increases the number of meal-induced transient lower esophageal sphincter relaxations (TLESRs) in healthy volunteers.

Authors:  J Halicka; P Banovcin; M Halickova; M Demeter; R Hyrdel; M Tatar; M Kollarik
Journal:  Neurogastroenterol Motil       Date:  2014-08-22       Impact factor: 3.598

5.  Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease.

Authors:  D Sifrim
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

6.  Mechanisms of excessive esophageal acid exposure in patients with reflux esophagitis.

Authors:  Katsuhiko Iwakiri; Noriyuki Kawami; Hirohito Sano; Yuriko Tanaka; Mariko Umezawa; Makoto Kotoyori; Yoshio Hoshihara; Choitsu Sakamoto
Journal:  Dig Dis Sci       Date:  2008-11-13       Impact factor: 3.199

7.  Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance.

Authors:  D Sifrim; J Silny; R H Holloway; J J Janssens
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

8.  Effect of increasing the fat content but not the energy load of a meal on gastro-oesophageal reflux and lower oesophageal sphincter motor function.

Authors:  R Penagini; M Mangano; P A Bianchi
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

9.  Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.

Authors:  G H Koek; D Sifrim; T Lerut; J Janssens; J Tack
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

10.  Gastroesophageal reflux disease: medical or surgical treatment?

Authors:  Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos
Journal:  Gastroenterol Res Pract       Date:  2009-12-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.